3D organotypic cell structures for drug development and Microorganism-Host interaction research

Authors

DOI:

https://doi.org/10.3897/rrpharmacology.7.62118

Abstract

Introduction: The article describes a new method of tissue engineering, which is based on the use of three-dimensional multicellular constructs consisting of stem cells that mimic the native tissue in vivo – organoids.

3D cell cultures: The currently existing model systems of three-dimensional cultures are described.

Characteristics of organoids and strategies for their culturing: The main approaches to the fabrication of 3D cell constructs using pluripotent (embryonic and induced) stem cells or adult stem cells are described.

Brain organoids (Cerebral organoids): Organoids of the brain, which are used to study the development of the human brain, are characterized, with the description of biology of generating region-specific cerebral organoids.

Lung organoids: Approaches to the generation of lung organoids are described, by means of pluripotent stem cells and lung tissue cell lines.

Liver organoids: The features of differentiation of stem cells into hepatocyte-like cells and the creation of 3D hepatic organoids are characterized.

Intestinal organoids: The formation of small intestine organoids from stem cells is described.

Osteochondral organoids: Fabrication of osteochondral organoids is characterised.

Use of organoids as test systems for drugs screening: The information on drug screening using organoids is provided.

Using organoids to model infectious diseases and study adaptive responses of microorganisms when interacting with the host: The use of organoids for modeling infectious diseases and studying the adaptive responses of microorganisms when interacting with the host organism is described.

Conclusion: The creation of three-dimensional cell structures that reproduce the structural and functional characteristics of tissue in vivo, makes it possible to study the biology of the body’s development, the features of intercellular interactions, screening drugs and co-cultivating with viruses, bacteria and parasites.

Keywords:

drug screening, microorganism-host interactions, organoids, 3D organotypic cell structures, tissue engineering

Author Contribution

Ekaterina V. Zubareva, Belgorod State National Research University

PhD in Biology, Associate Professor, Department of Biology

Sergey V. Nadezhdin, Belgorod State National Research University

PhD in Biology, Associate Professor, Head of the Research Laboratory Cellular, Assisted Reproductive and DNA Technologies

Natalia A. Nadezhdina, Children’s Regional Clinical Hospital

Otorhinolaryngologist, Children’s Regional Clinical Hospital

Veronika S. Belyaeva, Belgorod State National Research University

PhD student

Yuriy E. Burda, Belgorod State National Research University

PhD in Medicine, Associate Professor, Department of Pharmacology and Clinical Pharmacology

Tatyana V. Avtina, Belgorod State National Research University

PhD in Pharmacy, Associate Professor, Department of Pharmacology and Clinical Pharmacology

Oleg S. Gudyrev, Belgorod State National Research University

PhD in Medicine, Professor of the Department of Pharmacology and Clinical Pharmacology

Inga M. Kolesnik, Belgorod State National Research University

PhD in Medicine, Associate Professor, Department of Pharmacology and Clinical Pharmacology

Svetlana Yu. Kulikova, Belgorod State National Research University

PhD student

Mikhail O. Mishenin, Belgorod State National Research University

Assistant of the Department of General Practice Dentistry

Downloads

Published

31-03-2021

How to Cite

Zubareva EV, Nadezhdin SV, Nadezhdina NA, Belyaeva VS, Burda YE, Avtina TV, Gudyrev OS, Kolesnik IM, Kulikova SY, Mishenin MO (2021) 3D organotypic cell structures for drug development and Microorganism-Host interaction research. Research Results in Pharmacology 7(1): 47–64. https://doi.org/10.3897/rrpharmacology.7.62118

Issue

Section

Review article

Most read articles by the same author(s)

1 2 3 > >>